Description
Citraflee is not currently approved for clinical use in colorectal cancer and its efficacy and safety profile are still under investigation. It has not been incorporated into standard treatment regimens for CCR.
Mechanism of Action
Citraflee is an investigational drug and its mechanism of action has not been fully elucidated or approved by the FDA for clinical use in colorectal cancer.
Side Effects
None known at this time; further clinical trials are needed to determine potential side effects.
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
NCT07696793
Phase 4
Recruiting
Efficacy and Tolerability of a Simethicone-containing Evacuating Solution for Colorectal Cancer Screening Colonoscopy
Spain
NCT01689792
Phase 4
Archived
A Multi-centre Study Comparing the Polyp Detection Rate of Two Different Types of Bowel Preparation: a 2-litre Solution (MOVIPREP®) Versus a Hyperosmotic and Stimulant Combined Low Volume Bowel Preparation (Sodium Picosulfate and Magnesium Citrate)
Germany